Viewing Study NCT04261933


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-02-27 @ 5:22 PM
Study NCT ID: NCT04261933
Status: COMPLETED
Last Update Posted: 2023-03-28
First Post: 2020-02-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice (SURE GERMANY)
Sponsor: Novo Nordisk A/S
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: NN9535-4617
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators